PTPN11 and cardiac hypertrophy: LEOPARD syndrome patients most commonly manifest congenital heart defects and cardiac hypertrophy because of mutations in the PTPN11 gene encoding Shp2 that generally result in impaired Shp2 catalytic activity (21, 22).